A study on innovation incentive policy of pharmaceutical industry in China: A review
10.3969/j.issn.1674-2982.2017.08.007
- VernacularTitle:制药产业创新激励政策研究的述评与展望
- Author:
lin Cheng SHEN
1
;
xin Xin ZHANG
;
hua Wen HOU
Author Information
1. 天津工业大学管理学院 天津300387
- Keywords:
Pharmaceutical industry;
Innovation;
Incentive;
Regulation;
Policy
- From:
Chinese Journal of Health Policy
2017;10(8):34-39
- CountryChina
- Language:Chinese
-
Abstract:
Based on the typical characteristics of existing incentive and regulation in the pharmaceutical industry in China,the innovation incentive policy of the pharmaceutical industry can be divided into two types:incentive policy,and regulatory policy.This paper reviewed the research progress on the influence of price regulation policy,health insurance payment policy,centralized procurement regulation and incentive policy on the innovation of pharmaceutical industry.The present paper puts also forward the future research direction.Based on the literature review,it has been found that the futnre researches in this field should be based on the management practice situation in China,and make a breakthrough from the following three aspects-asymmetric information,comprehensive action mechanism from variable policy instruments,and introduction of new research paradigm.This research provides a theoretical reference for the research and decision-making of the innovation incentive policy in the pharmaceutical industry.
